Researchers found HIV survives treatment by hiding in gut mucosa, suppressing immune function. Early antiretroviral treatment and anti-inflammatory medications may improve treatment outcomes. Restoration of gut immune function is crucial to ridding the body of the virus.
A University of Houston team, with a NIH grant, is creating a quick, accurate test for the 'Cruise Ship Virus' using retroreflectors and antibody proteins. The tool has the potential to diagnose diseases like Norwalk more easily and may be applied to other infectious diseases.
A Case Report warns travelers of exposure to the rare chikungunya virus in Indian Ocean Islands, which causes fever, joint pain, and rash. The authors advise preventive measures against mosquito bites and recommend avoiding travel for vulnerable groups like pregnant women and older adults.
A study of 38 infant-mother pairs found that women who transmitted HIV to their babies had lower levels of a neutralizing antibody, suggesting its potential as a protective factor. The study suggests further research into the antibody's role could lead to an effective vaccine or passive antibody approaches.
A new international collaboration aims to identify genetic variations that affect the body's response to HIV. By analyzing patient cohorts from nine countries, researchers hope to pinpoint common genes influencing the disease progression and develop a vaccine targeting these responses.
The HBZ protein is crucial for persistent infection of HTLV-1 in an animal host. Researchers discovered that a drug targeting this protein could disrupt viral replication and provide a new therapy for infected individuals.
Researchers at Ohio State University Comprehensive Cancer Center identified the four stages of natural killer cell maturation in secondary lymphoid tissue, such as tonsils and lymph glands. This discovery could lead to new therapies for cancer, infection, and immune deficiencies, advancing our understanding of the human immune system.
A study published in the Proceedings of the National Academy of Sciences found that overexpression of microRNA miR155 leads to the development of a neoplastic disease in transgenic mice. The researchers believe that miR155 acts as an oncogene, promoting abnormal cell growth and cancerous transformations.
Researchers identify matrix protein as critical component in VSV's ability to invade cells and replicate, leading to potential vaccine development and anti-viral agents. The discovery also provides insights into how viruses shut down cell protein-making capabilities.
Researchers at Ohio State University have discovered that a cancer virus protein is necessary for the virus to successfully infect and reproduce in the body. The protein, p13, plays a critical role in the early phase of infection, and its function could be targeted by new drugs or vaccines.
The American Association for Cancer Research (AACR) has conferred its highest honors to several scientists for their groundbreaking contributions to cancer research. Carlo Croce and Wiliam Kaelin received awards for their pioneering work in leukemia and lymphoma research, while Julian Adams was recognized for his discovery of the first...
A study found that Vesivirus antibodies were present in over 40% of patients with clinical hepatitis, suggesting a potential link between the virus and human disease. The research also highlights the widespread distribution of Vesivirus in various animal species, including fish and primates.
Researchers found that carnivore parvoviruses and the human B19 erythrovirus undergo rapid evolution when switching host species. This contradicts the assumption that DNA viruses exhibit slower mutation rates compared to their hosts and other DNA viruses.
Two DNA repair proteins, XPB and XPD, can destroy HIV DNA, reducing viral replication and integration into host chromosomes. This finding may lead to new strategies for treating HIV infection and AIDS.
Researchers at Florida State University have discovered a molecular mechanism that inhibits HCV replication in vitro after host cells become crowded. The study's new test can quickly monitor HCV replication and has the potential to lead to better, targeted treatments for this complex virus.
Researchers discovered that bacteria can export molecules similar to communication signals, blocking the effectiveness of drugs. This process, called quorum sensing, allows bacteria to evade treatment and develop resistance to multiple drugs, making infections harder to treat.
Researchers identified a new gene associated with Charcot-Marie Tooth disease, a rare inherited neurological disorder. This discovery may lead to better understanding of how nerves function and improved diagnostic possibilities for CMT sufferers.
A common molecular signature of miRNA expression has been identified in solid tumors, providing insight into gene regulation and potential new approaches for diagnosis and treatment. This finding confirms the importance of microRNAs in growth and survival across species.
A vaccine developed by University of Pittsburgh Medical Center researchers has shown 100% protection against the avian flu virus in an animal study. The vaccine, which contains a live virus, stimulates several lines of immunity and is expected to have greater therapeutic value than traditional vaccines.
Researchers at Ohio State University have identified a novel lung-cancer tumor-suppressor gene, TCF21, which is silenced through DNA methylation. The study suggests that reactivating this gene may provide a new strategy for treating cancers, and the findings could lead to improved early detection methods for lung cancer.
Researchers at the University of Illinois have discovered a protein, MC160, that inhibits inflammatory responses by degrading a subunit of the immune system's IKK complex. This finding offers hope for treating conditions such as rheumatoid arthritis and Crohn's disease.
U.S. researchers have developed a new vaccine candidate against hepatitis C using dendritic cells, which reduced the amount of carrier virus expressing HCV protein in mice by 100,000 times compared to controls. The study's findings offer a promising approach to prevent liver disease and eliminate the virus from the body.
A new mass spectrometer design will enable scientists to analyze intact protein complexes in seconds, avoiding sample loss and improving research efficiency. This breakthrough technology could revolutionize fields like proteomics, virology, and nanotechnology.
Researchers at Thomas Jefferson University have identified a molecular mechanism involved in making the rabies virus pathogenic and lethal. They have developed a very safe vaccine for the immunization of wildlife, showing efficacy in raccoon, skunk, and mongoose species, offering new hope for prevention of deadly disease.
The study reveals that the EBNA3C protein recruits a complex to degrade the retinoblastoma protein (Rb), leading to uncontrollable cell proliferation. This finding holds promise for developing new treatments for EBV-associated B cell lymphomas and other blood cancers.
Cedars-Sinai researchers have developed a new delivery system that can effectively regulate therapeutic gene expression, overcoming obstacles in bringing genetic therapies to humans. The system allows for the flexibility to turn gene expression on or off, even in the presence of an immune response, making it a critical tool for treatin...
Researchers discovered that Francisella tularensis can bypass the immune system's sensors and only triggers a response once inside a monocyte. This finding may lead to better treatments for diseases like tuberculosis and the plague. Understanding how the human immune system reacts to F. tularensis could provide new avenues for treatment.
Researchers found that identical twins infected with the same HIV strain had different T-cell receptor characteristics, indicating a random and unpredictable immune response. This discovery challenges the idea of developing a single, universal vaccine for everyone.
Researchers at Ohio State University found that stress and hostility can significantly slow the healing process, taking up to two days longer for wounds to heal. Cytokine levels also increased in highly stressed couples, leading to chronic inflammation and age-related illnesses.
A new high-affinity antibody successfully eliminated anthrax bacteria and its deadly toxins in animal tests, offering a promising treatment for late-stage anthrax infection. The antibody produced in bacterial cells could lead to a simpler and cheaper way to treat anthrax, providing an effective treatment that doesn't require antibiotics.
A new study suggests that malaria may play a key role in mother-to-child transmission of HIV during pregnancy, with high levels of proinflammatory cytokines stimulating HIV replication. Researchers are calling for further investigation and consideration of routine testing and treatment to reduce fetal infection risks.
Researchers have discovered a key process underlying CML progression and identified an agent that can block it. Forskolin restores normal cell functioning in Gleevec-resistant cells, offering new treatment options for patients with advanced or resistant disease.
Researchers link muscular dystrophy and cancer-associated muscle wasting to dysfunctional dystrophin glycoprotein complex. Cachectic patients with gastrointestinal cancers show dramatic reductions in dystrophin levels, highlighting the shared mechanism of DGC dysfunction as a critical characteristic.
Researchers at Ohio State University discover cancer wasting is caused by loss of muscle protein dystrophin and damage to the dystrophin glycoprotein complex. This finding may lead to new ways to diagnose and treat the condition.
A new test developed by a McMaster virologist can identify infected individuals early in an outbreak, limiting the spread of virus in the community. The test will be available for evaluation by hospital-based laboratories and reference laboratories by early December.
A study published in the Journal of Immunology suggests that the immune-cell substance MIF may be necessary for multiple sclerosis progression, but less important for initiating the disease. Researchers found that mice lacking MIF developed an acute phase of the disease, but then recovered without further signs of progression.
Researchers at Ohio State University discovered that restoring the missing or silenced WWOX gene can slow or stop lung-cancer cell growth. The study showed that reactivating the gene is highly effective in stopping human lung tumor growth in mice, suggesting a potential therapeutic approach for lung cancer treatment.
A study of 1212 children and 446 Italian Air Force recruits found that infant and adolescent immune systems can recall responding to hepatitis B more than 10 years after immunisation. The findings suggest that routine booster doses may not be necessary for long-term protection, even in high-risk populations.
An international team of researchers suggests that people at high risk of contracting HIV should take daily antiretroviral medication as a preventative measure. This approach, known as PrEP, has been shown promise in clinical trials and is seen as a crucial strategy to combat the ongoing pandemic.
Key findings highlight the importance of early community involvement, clear communication, and local infrastructure development in HIV pre-exposure chemoprophylaxis research. The commentary advocates for partnerships between sponsors, investigators, communities, and governments to build trust and achieve successful research outcomes.
Researchers find that HIV in the temporal lobe mutates rapidly, triggering an immune response that causes dementia. The study suggests targeting infected white blood cells could lead to new treatments for HIV-related brain damage, affecting up to 15% of infected individuals worldwide.
Scientists at Vanderbilt University Medical Center discovered compounds secreted by frog skin can selectively kill HIV without harming T cells. The findings hold promise for developing new treatments and vaccines against the virus.
Researchers have discovered a novel mechanism used by tick-borne flaviviruses to counteract the natural ability of interferon to combat the virus. The study found that NS5 protein blocks immune defenses, preventing the immune system from stopping the spread of the virus and helping the body recover from infection.
Robert Gallo emphasizes the need for a rational approach to HIV vaccine development, ignoring empirically driven methods and focusing on solid knowledge of HIV biology. He suggests leveraging the Gates's Foundation's Grand Challenge for Global Health to find practical solutions to scientific roadblocks.
A new strain of equine influenza virus, H3N8, has been found to infect dogs in the US, with close to 100% of infected dogs showing symptoms. The virus is highly contagious and can spread rapidly throughout dog populations, making it a major concern for dog owners.
Mutations in the EphB2 gene are found in 15% of African-American men with a strong family history, compared to 5% without a history. This gene mutation is associated with an increased risk of prostate cancer in African-American men, particularly those with a family history.
Researchers have identified a protein in the smallpox virus that elicits a strong human antibody response, providing potential protection against the lethal virus. The discovery could lead to the development of an effective treatment for smallpox, offering immediate protection to individuals at risk.
Researchers have developed RNA nanoparticles that can carry multiple therapeutic agents into specific cancer cells, where they can halt viral growth or cancer progression. The tiny particles are assembled from three short pieces of ribonucleic acid and possess the right size and structure to gain entry into cells.
A study found that HIV-infected macrophages travel to the temporal lobe, causing inflammation and damaging memories. Researchers hope to develop drugs targeting these cells to prevent HIV-associated dementia.
The Gladstone Institutes will develop a core curriculum of required and elective courses spanning various stem cell research disciplines. The CIRM Scholars Training Program aims to advance regenerative medicine by focusing on understanding the fundamental mechanisms related to stem cells.
Researchers at UGA College of Veterinary Medicine have identified a new way to combat viral diseases by blocking a protein that helps transport viruses out of cells. This approach, targeting the host gene Rab9, shows promise in preventing the replication of four different viruses: Marburg, Ebola, HIV-1, and measles.
Chronic leukemia affects 9,700 Americans annually, with unusual microRNAs enabling damaged cells to survive. Researchers discovered that miR-15 and miR-16 play a crucial role in controlling Bcl-2 levels, leading to tumor growth.
Analysis of M2 protein sequence data reveals higher resistance to antiviral drug amantadine in Southeast Asian H5N1 viruses, especially in China. This suggests selective pressure may be driving the emergence of resistant strains through human activities.
A new study confirms that APOBEC-3G edits the HIV genetic code, preventing viral reproduction. Higher levels of A3G are associated with lower HIV viral levels and higher CD4 T cell counts in patients. This discovery holds promise for a novel approach to fight HIV.
A study from Ohio State University's Comprehensive Cancer Center discovered a set of microRNAs that can distinguish between normal and cancerous breast tissue. The findings suggest that microRNA expression is correlated with breast cancer's hormone status, metastatic potential, and proliferative rate.
Researchers have developed a way to engineer an alternative outer covering for the measles virus, allowing it to recognize and target only cancerous cells. The 'virus in stealth' approach uses pieces from an animal virus that cannot infect humans to disguise the measles virus, enabling it to evade the immune system and reach tumors.
Scientists at Ohio State University created a mouse model of lung cancer that loses the FHIT gene's protein early in development, leading to larger and more numerous tumors. The study suggests that even low levels of the protein might prevent lung cancer.
Researchers at the University of Michigan have identified a receptor, dubbed B5, that plays a crucial role in the herpes simplex virus's ability to infect human cells. The team has developed a pig-cell system that could be used to test new anti-herpes drugs and has discovered that blocking the B5 receptor can prevent viral infection.
A new study published in Virology suggests that some strains of monkeypox are more virulent than others, depending on their origin in Africa. The 2003 US outbreak was caused by a West African virus, which may have been less deadly due to its strain.
Researchers found that identical twins may have more differences than expected due to epigenetic changes. The study analyzed epigenetic changes in 40 pairs of twins and found that those with greater health differences had higher methylation levels, which could impact cancer development.